Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling.

Saved in:
Bibliographic Details
Title: Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling.
Authors: Alomari, Ghada1 (AUTHOR) Ghada.o@yu.edu.jo, Al-Trad, Bahaa2 (AUTHOR) baltrad@kfu.edu.sa, Qar, Janti1 (AUTHOR), Tahat, Lena1 (AUTHOR), Abu Haija, Yazan1 (AUTHOR), Al-najjar, Aseel1 (AUTHOR), Albokhadaim, Ibrahim2 (AUTHOR), Shousha, Saad2 (AUTHOR), Alameen, Ahmed O.2 (AUTHOR), Shukry, Mustafa2 (AUTHOR)
Source: Scientific Reports. 4/7/2026, Vol. 16 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-026-47374-0